Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

W. Evans · SciRah

Researcher profile · Semantic Scholar

W. Evans

Share profile

W. Evans — researcher profile on SciRah

h-index: 40
Works: 206
Citations: 6,561

Most-cited papers

The Management of Thymoma: A Systematic Review and Practice Guideline
C. Falkson, A. Bezjak, G. Darling, R. Gregg +7 more
2009Journal of Thoracic Oncology271 citations Open access
Semantic Scholar
First-Line Systemic Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer: A Systematic Review
J. Goffin, C. Lacchetti, P. Ellis, Y. Ung +1 more
2010Journal of Thoracic Oncology203 citations Open access
Semantic Scholar
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
M. Tammemagi, H. Schmidt, S. Martel, A. Mcwilliams +44 more
2017The Lancet Oncology188 citations
Semantic Scholar
Positron Emission Tomography-Computed Tomography Compared with Invasive Mediastinal Staging in Non-small Cell Lung Cancer: Results of Mediastinal Staging in the Early Lung Positron Emission Tomography Trial
G. Darling, D. Maziak, R. Inculet, K. Gulenchyn +8 more
2011Journal of Thoracic Oncology149 citations Open access
Semantic Scholar
Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial.
N. Mittmann, H. Au, D. Tu, C. O'Callaghan +13 more
2009Journal of the National Cancer Institute140 citations Open access
Semantic Scholar
The Cost‐Effectiveness of High‐Risk Lung Cancer Screening and Drivers of Program Efficiency
S. Cressman, S. Peacock, M. Tammemagi, W. Evans +35 more
2017Journal of Thoracic Oncology134 citations Open access
Semantic Scholar
Accelerated care versus standard care among patients with hip fracture: the HIP ATTACK pilot trial
Cares investigators, G. L. Buse, M. Bhandari, P. Sancheti +44 more
2013Canadian Medical Association Journal120 citations Open access
Semantic Scholar
Positron Emission Tomography in Staging Early Lung Cancer
D. Maziak, G. Darling, R. Inculet, K. Gulenchyn +7 more
2009Annals of Internal Medicine116 citations Open access
Semantic Scholar
Cost-effectiveness of Lung Cancer Screening in Canada.
J. Goffin, W. Flanagan, A. Miller, N. Fitzgerald +3 more
2015JAMA Oncology115 citations Open access
Semantic Scholar
Economic analysis: randomized placebo-controlled clinical trial of erlotinib in advanced non-small cell lung cancer.
P. Bradbury, D. Tu, L. Seymour, P. Isogai +7 more
2010Journal of the National Cancer Institute83 citations Open access
Semantic Scholar
Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trial.
Charles Lu, J. Lee, R. Komaki, R. S. Herbst +10 more
2010Journal of the National Cancer Institute73 citations Open access
Semantic Scholar
Economic guidelines for oncology products: Adaptation of the Canadian Agency for Drugs and Technologies in Health (CADTH) technology assessment guidance document.
N. Mittmann, W. Evans, Angela Rocchi, C. Longo +5 more
2009Journal of Clinical Oncology73 citations
Semantic Scholar
Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs.
S. Berry, C. Bell, P. Ubel, W. Evans +3 more
2010Journal of Clinical Oncology71 citations Open access
Semantic Scholar
Health system costs for stage-specific breast cancer: a population-based approach.
N. Mittmann, J. Porter, Jagadish Rangrej, Soo Seung +10 more
2014Current Oncology66 citations Open access
Semantic Scholar
Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness.
J. Goffin, W. Flanagan, A. Miller, N. Fitzgerald +3 more
2016Lung Cancer61 citations
Semantic Scholar
Clinical Utility of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Staging of Patients with Potentially Resectable Esophageal Cancer
J. You, R. Wong, G. Darling, K. Gulenchyn +2 more
2013Journal of Thoracic Oncology48 citations Open access
Semantic Scholar
Resource Utilization and Costs during the Initial Years of Lung Cancer Screening with Computed Tomography in Canada
S. Cressman, S. Lam, M. Tammemagi, W. Evans +39 more
2014Journal of Thoracic Oncology44 citations Open access
Semantic Scholar
Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model.
W. Evans, C. Gauvreau, W. Flanagan, S. Memon +5 more
2020CMAJ Open31 citations Open access
Semantic Scholar
Eligibility for low-dose computerized tomography screening among asbestos-exposed individuals.
N. Fitzgerald, W. Flanagan, W. Evans, A. Miller
2015Scandinavian Journal of Work, Environment and Health31 citations Open access
Semantic Scholar
In A Survey, Marked Inconsistency In How Oncologists Judged Value Of High-Cost Cancer Drugs In Relation To Gains In Survival
P. Ubel, S. Berry, E. Nadler, C. Bell +5 more
2012Health Affairs31 citations Open access
Semantic Scholar
Improving the Quality of Lung Cancer Care in Ontario: The Lung Cancer Disease Pathway Initiative
W. Evans, Y. Ung, N. Assouad, Anna Chyjek +1 more
2013Journal of Thoracic Oncology27 citations Open access
Semantic Scholar
Evidence-based approach to the introduction of positron emission tomography in ontario, Canada.
W. Evans, A. Laupacis, K. Gulenchyn, L. Levin +1 more
2009Journal of Clinical Oncology25 citations
Semantic Scholar
Utilization and costs of home care for patients with colorectal cancer: a population-based study.
N. Mittmann, Ning Liu, J. Porter, Soo Seung +9 more
2014CMAJ Open23 citations Open access
Semantic Scholar
Advances in Cancer Therapeutics and Patient Access to New Drugs
G. Dranitsaris, I. Truter, M. Lubbe, E. Amir +1 more
2011PharmacoEconomics (Auckland)23 citations
Semantic Scholar
Health system costs for cancer medications and radiation treatment in Ontario for the 4 most common cancers: a retrospective cohort study.
N. Mittmann, Ning Liu, Stephanie Y. Cheng, Soo Seung +8 more
2020CMAJ Open22 citations Open access
Semantic Scholar
Computed tomography screening for lung cancer without a smoking cessation program--not a cost-effective idea.
W. Evans, M. Wolfson
2011Journal of Thoracic Oncology21 citations Open access
Semantic Scholar
Implementing smoking cessation within cancer treatment centres and potential economic impacts.
W. Evans, R. Truscott, E. Cameron, S. Rana +3 more
2019Translational Lung Cancer Research20 citations Open access
Semantic Scholar
A mixed methods approach to understand variation in lung cancer practice and the role of guidelines
M. Brouwers, J. Makarski, K. Garcia, S. Akram +6 more
2014Implementation Science19 citations Open access
Semantic Scholar
Positron Emission Tomography with 18Fluorodeoxyglucose in Radiation Treatment Planning for Non-small Cell Lung Cancer: A Systematic Review
Y. Ung, A. Bezjak, N. Coakley, W. Evans
201118 citations Open access
Semantic Scholar
Performance of the cancer risk management model lung cancer screening module.
W. Flanagan, W. Evans, N. Fitzgerald, J. Goffin +2 more
2015Health reports16 citations
Semantic Scholar
Awareness of the Harms of Continued Smoking Among Cancer Survivors
L. Eng, D. Alton, Yu-Yao Song, Jie Su +22 more
2019Supportive Care in Cancer15 citations
Semantic Scholar
The generation of two specific cancer costing algorithms using Ontario administrative databases.
N. Mittmann, Stephanie Y. Cheng, Ning Liu, Soo Seung +8 more
2019Current Oncology14 citations Open access
Semantic Scholar
Development, validation and results from the impact of treatment evolution in non-small cell lung cancer (iTEN) model.
D. Moldaver, M. Hurry, W. Evans, P. Cheema +9 more
2019Lung Cancer14 citations Open access
Semantic Scholar
Prognostic implications of treatment delays in the surgical resection of lung cancer.
W. Evans
2013Thoracic Surgery Clinics14 citations
Semantic Scholar
How equitable is access to treatment for lung cancer patients? A population-based review of treatment practices in Ontario
W. Evans, Jennifer Stiff, K. Woltman, Y. Ung +9 more
2017Lung Cancer Management13 citations Open access
Semantic Scholar
An Ontario Clinical Oncology Group (OCOG) randomized trial (PET START) of FDG PET/CT in patients with stage III non-small cell lung cancer (NSCLC): Predictors of overall survival.
Yee C. Ung, C. Gu, K. Cline, Alexander Sun +13 more
2011Journal of Clinical Oncology13 citations
Semantic Scholar
Towards Integrating Primary Care with Cancer Care: A Regional Study of Current Gaps and Opportunities in Canada
J. Sussman, D. Bainbridge, W. Evans
2017Healthcare Policy | Politiques de Santé12 citations Open access
Semantic Scholar
End-of-life home care utilization and costs in patients with advanced colorectal cancer.
N. Mittmann, Ning Liu, J. Porter, P. Isogai +8 more
2014The Journal of Community and Supportive Oncology12 citations Open access
Semantic Scholar
The evaluation of cancer control interventions in lung cancer using the Canadian Cancer Risk Management Model
W. Evans, M. Wolfson, W. Flanagan, Janey Shin +11 more
201212 citations
Semantic Scholar
Critical Determinants of Cancer Treatment Outcomes: Smoking Must Be Addressed at the Highest Levels in Cancer Care.
G. Warren, W. Evans, C. Dresler
2021Journal of Thoracic Oncology11 citations Open access
Semantic Scholar
Guidelines for health technologies: specific guidance for oncology products in Canada.
N. Mittmann, W. Evans, Angela Rocchi, C. Longo +11 more
2012Value in Health11 citations Open access
Semantic Scholar
Variation and consternation: access to unfunded cancer drugs in Canada.
S. Berry, W. Evans, E. Strevel, C. Bell
2012Journal of Oncology Practice10 citations Open access
Semantic Scholar
Measuring value and benefit-a matter of perspective.
W. Evans, M. Cheung, K. Chan
2017The Lancet Oncology9 citations
Semantic Scholar
Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial).
M. Reaume, N. Leighl, N. Mittmann, D. Coyle +10 more
2013Lung Cancer9 citations
Semantic Scholar
Impact of positron emission tomography (PET) in stage III non-small cell lung cancer (NSCLC): A prospective randomized trial (PET START).
Yee C. Ung, Alexander Sun, R. MacRae, C. Gu +6 more
2009Journal of Clinical Oncology8 citations
Semantic Scholar
Comparing assessment frameworks for cancer drugs between Canada and Europe: What can we learn from the differences?
M. Cheung, K. Chan, M. Sabharwal, A. Fields +2 more
2016ESMO Open7 citations Open access
Semantic Scholar
Sociodemographic characteristics associated with thyroid cancer risk in Canada.
T. Bushnik, W. Evans
2018Health reports6 citations
Semantic Scholar
Evaluating Cost-Effectiveness: An Essential Part of New Cancer Drug Approvals.
W. Evans, C. de Oliveira
2017Journal of Thoracic Oncology6 citations Open access
Semantic Scholar
Ignoring the Obvious: Smoking Cessation Improves Survival.
W. Evans, G. Warren, Carolyn M. Dresler
2022Journal of Thoracic Oncology5 citations Open access
Semantic Scholar
OA09.02 Acceptance of Smoking Cessation Services in Cancer Care Ontario’s Lung Cancer Screening Pilot for People at High Risk
W. Evans, G. Darling, Beth Miller, E. Cameron +2 more
2018Journal of Thoracic Oncology5 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Leighl×10
Invite
N. Leighl — researcher profile on SciRah
J. Goffin×9
Invite
J. Goffin — researcher profile on SciRah
Y. Ung×8
Invite
Y. Ung — researcher profile on SciRah
N. Mittmann×8
Invite
N. Mittmann — researcher profile on SciRah

×7

Invite

G. Darling — researcher profile on SciRah

Invite

W. Flanagan — researcher profile on SciRah

Invite

M. Wolfson — researcher profile on SciRah

Invite

M. Cheung — researcher profile on SciRah

K. Gulenchyn×5

Invite

K. Gulenchyn — researcher profile on SciRah

Invite

P. Isogai — researcher profile on SciRah

Invite

A. Miller — researcher profile on SciRah

N. Fitzgerald×5

Invite

N. Fitzgerald — researcher profile on SciRah